Matrix metalloproteinases (MMPs) in health and disease: An overview

Frontiers in Bioscience

Volumn 11, Issue 2 P.1591-2006, 2006, Pages 1696-1701

  Malemud, Charles J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Arthritis; Cancer; Cardiovascular; Cerebral ischemia; Gene transcription; Growth plate; Matrix metalloproteinase; Protein kinase; TIMP

Indexed keywords

EID: 31744445961     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1915     Document Type: Review

References (50)

1. J S Mort & A R Poole: Mediators of inflammation, tissue destruction and repair. D. Proteases and their inhibitors. In: Primer on the rheumatic diseases, Edition 12. Ed: Klippel JH, Arthritis Foundation, GA 72-81 (2001)
2. R. L. Smith: Degradative enzymes in osteoarthritis: Front Biosci 4, d704-712 (1999)
3. J Martel-Pelletier, J Di Battista & J-P Pelletier: Biochemical factors in joint articular tissue degradation in osteoarthritis. In: Osteoarthritis. Clinical and experimental aspects. Eds: Reginster J-Y, Pelletier J-P, Martel-Pelletier J., Henrotin Y, Springer, Germany 156-187 (1999)
4. J F Woessner, Jr: Imbalance of proteinases and their inhibitors in osteoarthritis. In: Osteoarthritic disorders. Eds: Kuettner KE, Goldberg VM, American Association of Orthopaedic Surgeons, IL 281-290 (1995)
5. H. Nagase & M. Kashiwagi: Aggrecanases and cartilage matrix degradation. Arthritis Res Ther, 5(2), 94-103 (2003)
6. N. Ortega, D. Behonick, D. Stickens & Z. Werb: How proteases regulate bone morphogenesis. Ann NY Acad Sci 995, 109-116 (2003)
7. M. D. Sternlicht & G. Bergers: Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects. Emerg Ther Targets 4(5), 609-633 (2000)
8. F. C. Luft: Matrix metalloproteinases and their regulators are cardiovascular therapeutic targets. J Mol Med 82 (12), 781-783 (2004)
9. L. A. Cunningham, M. Wetzel & G. A. Rosenberg: Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50(4), 329-339 (2005)
10. M. R. Michaelides & M. L. Curtin: Recent advances in matrix metalloproteinase inhibitors research. Curr Pharm Des 5(10), 787-819 (1999)
11. C. J. Malemud: Protein kinases in chondrocyte signaling and osteoarthritis. Clin Orthop Relat Res 427 Suppl, S145-151 (2004)
12. H. C. Crawford & L. M. Matrisian: Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic tissue. Enzyme Protein 49(1-3), 20-37 (1996)
13. C. M. Overall, J. L. Wrana & J. Sodek: Transcriptional and post-transcriptional regulation of 72 kDa gelatinase/type IV collagenase by transforming growth factor-beta1 in human fibroblasts. J Biol Chem 266(21), 14064-14071 (1991)
14. S. D. Shapiro, G. A. Doyle, T. J. Ley, W. C. Parks & H. G. Welgus: Molecular mechanisms regulating the production of collagenase and TIMP in U937 cells: evidence for involvement of delayed transcriptional activation and enhanced mRNA stability. Biochemistry 32(16), 4286-4292 (1993)
15. C. J. Malemud, N. Islam & T. M. Haqqi: Pathophysiologic mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174(1-2), 34-48 (2003)
16. C. M. Overall & C. Lopez-Otin: Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2(9), 657-672 (2002)
17. Z. Werb & J. R. Chin: Extracellular matrix remodeling during morphogenesis. Ann NY Acad Sci 857, 110-118 (1998)
18. T. Kobayashi, U. I. Chung, E. Shipani, M. Starbuck, G. Karsenty, T. Katagiri, D. L. Goad, B. Lanske & H. M. Kronenberg: PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development 129(12), 2977-2986 (2002)
19. Y. Wang, F. Middleton, J. A. Horton, L. Reichel, C. E. Farnum & T. A. Damron: Microarray analysis of proliferative and hypertrophic growth plate zones identifies differentiation markers and signal pathways. Bone 35(6), 1273-1293 (2004)
20. T. H. Vu, J. M. Shipley, G. Bergers, J. E. Berger, J. A. Helms, D. Hanshan, S. D. Shapiro, R. M. Senior & Z. Werb: MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93(3), 411-422 (1998)
21. M. Inada, Y. Wang, M. H. Byme, M. U. Rahman, C. Miyaura, C. Lopez-Ortin & S. M. Krane: Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci USA 101(49), 17192-17197 (2004)
22. D. Stickens, D. J. Behonick, N. Ortega, B. Heyer, B. Hartenstein, Y. Yu, A. J. Fosang, M. Schorp-Kistner, P. Angel & Z. Werb: Altered endochondral bone formation in matrix metalloproteinase 13-deficient mice. Development 131(23), 5883-5895 (2004)
23. K. Holmbeck, P. Bianco, J. Caterina, S. Yamada, M. Kromer, S. A. Kuznesov, M. Mankani, P. G. Robey, A. R. Poole, I. Pidoux, J. M. Ward & H. Birkdal-Hansen: MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis and connective tissue disease due to inadequate collagen turnover. Cell 99(1), 81-92 (1999)
24. S. S. Glasson, R. Askew, B. Sheppard, B. A. Carito, T. Blanchet, H. L. Ma, C. R. Flannery, K. Kanki, E. Wang, D. Peluso, Z. Yang, M. K. Majumdar & E. A. Morris: Characterization of and osteoarthritic susceptibility in ADAMTS-4 knock out mice. Arthritis Rheum 50(8), 2547-2558 (2004)
25. S. S. Glasson, R. Askew, B. Sheppard, B. Carito, T. Blanchet, H-L Ma, C. R. Flannery, D. Peluso, K. Kanki, Z. Yang, M. K. Majumdar & E. A. Morris: Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434(7033), 644-648 (2005)
26. W. Wu, F. Mwale, E. Tchetina, T. Kojima, T. Yasuda & A. R. Poole: Cartilage matrix resorption in skeletogenesis. Novartis Found Symp 232, 158-166 (2001)
27. G. Haeusler, I. Walter, M. Helmreich & M. Egerbacher: Localization of matrix metalloproteinases (MMFs), their tissue inhibitors and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal development and skeletal maturation. Calc Tissue Int 76(5), 326-335 (2005)
28. J. R. Robbins, P. G. McGuire, B. Wherle-Haller & S. L. Rogers: Diminished matrix metalloproteinase 2 (MMP-2) in ectomesenchyme-derived tissues of the Patch mutant mouse: regulation of MMP-2 by PDGF and effects of mesenchymal cell migration. Dev Biol 212(2), 255-263 (1999)
29. Z. S. Galis, G. K. Sukhova, M. W. Lark & P. Libby: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94(6), 2493-2503 (1994)
30. C. Lovdahl, J. Thyberg, B. Cercek, K. Blomgren, P. Dimayuga, B. Kallin & A. Hultgardh-Nilson: Antisense oligonucleotides to stromelysin mRNA inhibit injury-induced proliferation of arterial smooth muscle cells. Histol Histopathol 14(4), 1101-1112 (1999)
31. C. M. Longo, W. Xiong, T. C. Greiner, Y. Zhao, N. Fiotti & B. T. Baxter: Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110(5), 625-632 (2002)
32. C. C. Danielson, H. Wiggers & H. R. Andersen: Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. J Mol Cell Cardiol 30(7), 1431-1442 (1998)
33. T. Yamazaki, J. D. Lee, H. Shimuzu, H. Uzui & T. Ueda: Circulating matrix metalloproteinase 2 is elevated in patients with congestive heart failure. EwJ Heart Fail 6(1), 41-45 (2004)
34. G. M. Kammer, A. I. Sapolsky & C. J. Malemud: Secretion of an articular cartilage proteoglycan-degrading enzyme activity by murine T lymphocytes in vitro. J Clin Invest 76(2), 395-402 (1985)
35. C. J. Malemud: Cytokines as therapeutic targets for osteoarthritis. Biodrugs 18(1), 23-35 (2004)
36. C. J. Malemud & H. J. Gillespie: The role of apoptosis in arthritis. Curr Rheumatol Rev 1(2), 131-142 (2005)
37. C. E. Brinckerhoff & L. A. Matrisian: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3(3), 207-214 (2002)
38. M. D. Tortorella, A.- M. Malfait, C. Deccico & E. Arner: The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 9(6), 539-552 (2001)
39. S. Porter, I. M. Clark, L. Kevorkian & D. R. Edwards: The ADAMTS metalloproteinases. Biochem J 386 (Pt 1), 15-27 (2004)
40. M. E. Weinblatt, E. C. Keystone, D. E. Furst, L. W. Moreland, M. H. Weisman, C. A. Birbara, L. A. Teoh, L. A. Fischkoff & E. K. Chartash: Adalimumab, a fully human anti-tumor necrosis-alpha monoclonal antibody, for the treatment of rheumatoid arthritis patients taking concomitant methotrexate: the ARMADA trial Arthritis Rheum 48(1), 35-45 (2003)
41. L. M. Coussens, B. Fingleton & L. M. Matrisian: Matrix metalloproteinase inhibitors and cancer trials and tribulations. Science 295(5564), 2387-2392 (2002)
42. J. Folkmann: Endogenous angiogenesis inhibitors. APMIS 112(7-8), 496-507 (2004)
43. B. Fingleton.: Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects. Expert Opin Ther Targets 7(3), 385-397 (2003)
44. D. Hanahan & R. A. Weinberg: The hallmarks of cancer. Cell 100(1), 57-70 (2000)
45. B.-C. Sheu, S.-M. Hsu, H.-N. Ho, H.-C.Lien, S.-C. Huang & R.-H. Lin: A novel role of metalloproteinase in cancer mediated immunosuppression. Cancer Res 61(1), 237-242 (2001)
46. V.W. Yong, C. Power, P. Forsyth & D. R. Edwards: Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2(7), 502-511 (2001)
47. D. Leppert, S. L. Leib, C. Grygar, K. M. Miller, U. B. Schaad & G. A. Hollander: Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis 31(1), 80-84 (2000)
48. V. Ozenci, M. Kouwenhoven, N. Teleshova, M. Pashenkov, S. Fredrikson & H. Link: Multiple sclerosis: pro-and anti-inflammatory cytokines and metalloproteinases are affected differently by treatment with IFN-beta. J Neuroimmunol 108(1-2), 236-243 (2000)
49. V. W. Yong, C.A. Krekoski, P. A. Forsyth, R. Bell & D. R. Edwards: Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21(2), 75-80 (1998)
50. M. Nakada, Y. Okada & J. Yamashita: The role of matrix metalloproteinases in glioma invasion. Front Biosci 8: 6261-269 (2003)